Medicare Enrolled
Dr. Jesus Arenas, M.D.
Dermatology · La Puente, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arenas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arenas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arenas
Dr. Jesus Arenas is a dermatology specialist in La Puente, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Arenas performed 7,606 Medicare services across 3,396 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arenas received a total of $12,770 from 32 pharmaceutical and/or device companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arenas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$12,770 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,606
Medicare services
Top 7% in CA for dermatology
3,396
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~400 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
1,907 | $86 | $159 |
| Prolonged home visit care, each 15 minutes This code covers additional time spent by a physician or qualified professional providing care at a patient's home beyond the standard duration of the primary visit. It is billed in 15-minute increments for the extra time dedicated to the patient's evaluation and management. |
1,234 | $26 | $50 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
1,096 | $155 | $275 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
803 | $73 | $135 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
433 | $35 | $76 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
425 | $44 | $95 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $68 | $205 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
262 | $29 | $60 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
164 | $100 | $399 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
129 | $106 | $192 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
101 | $11 | $50 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
100 | $74 | $135 |
| Home visit, new patient, high complexity A home visit for a new patient involving high-level medical decision making, lasting at least 75 minutes. |
98 | $163 | $322 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
96 | $140 | $195 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
94 | $111 | $201 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
93 | $76 | $125 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
52 | $176 | $253 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $145 | $500 |
| Home visit, new patient, moderate complexity A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes. |
30 | $114 | $280 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $12 | $35 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
23 | $22 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $33 | $40 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
17 | $68 | $318 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,770
Total received (2018-2024)
Avg $1,824/year across 7 years
Top 4% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
474
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,410 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$360 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,096
2023
$2,178
2022
$1,676
2021
$1,678
2020
$1,187
2019
$1,771
2018
$2,183
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$673
Novo Nordisk Inc
$322
AstraZeneca Pharmaceuticals LP
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$198
GlaxoSmithKline, LLC.
$133
Lilly USA, LLC
$108
Sumitomo Pharma America, Inc.
$103
Janssen Pharmaceuticals, Inc
$71
Esperion Therapeutics, Inc.
$69
GENZYME CORPORATION
$64
Bayer Healthcare Pharmaceuticals Inc.
$23
Kowa Pharmaceuticals America, Inc.
$22
PFIZER INC.
$20
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,463
Novo Nordisk Inc
$1,993
AstraZeneca Pharmaceuticals LP
$1,817
Janssen Pharmaceuticals, Inc
$1,574
Boehringer Ingelheim Pharmaceuticals, Inc.
$598
Kowa Pharmaceuticals America, Inc.
$573
Lilly USA, LLC
$524
Astellas Pharma US Inc
$484
SANOFI-AVENTIS U.S. LLC
$337
Merck Sharp & Dohme LLC
$323
GlaxoSmithKline, LLC.
$313
Bayer Healthcare Pharmaceuticals Inc.
$302
Sumitomo Pharma America, Inc.
$255
Bayer HealthCare Pharmaceuticals Inc.
$183
Esperion Therapeutics, Inc.
$166
Merck Sharp & Dohme Corporation
$159
Amarin Pharma Inc.
$149
PFIZER INC.
$80
GENZYME CORPORATION
$64
Horizon Therapeutics plc
$61
Allergan, Inc.
$56
Ultragenyx Pharmaceutical Inc.
$45
Novartis Pharmaceuticals Corporation
$41
UCB, Inc.
$39
Genentech USA, Inc.
$36
SK Life Science, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$24
E.R. Squibb & Sons, L.L.C.
$19
Philips Electronics North America Corporation
$19
Grifols USA, LLC
$18
Exact Sciences Corporation
$16
Medtronic MiniMed, Inc.
$14
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
(9061) SRC Sol Space · AIRSUPRA · ANORO · AREXVY · Aimovig · BAQSIMI · BELSOMRA · BREZTRI · Briviact · Cologuard Collection Kit · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · GEMTESA · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · KRYSTEXXA · Kerendia · LIVALO · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · Otezla · Ozempic · PENNSAID · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Prolia · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · Seglentis · TAVNEOS · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VERQUVO · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · Xofluza · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
472
Per 100K population
4.8
County median income
$87,760
Nearest hospital
EMANATE HEALTH INTER-COMMUNITY HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Arenas is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Arenas experienced with home health agency supervision, complex multidisciplinary care?
Based on Medicare claims data, Dr. Arenas performed 1,907 home health agency supervision, complex multidisciplinary care services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arenas receive payments from pharmaceutical companies?
Yes. Dr. Arenas received a total of $12,770 from 32 companies across 474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arenas's costs compare to other dermatologists in La Puente?
Dr. Arenas's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arenas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in La Puente
Browse dermatologists in La Puente ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology